Literature DB >> 10681529

Cysteine-rich protein 2, a novel substrate for cGMP kinase I in enteric neurons and intestinal smooth muscle.

A Huber1, W L Neuhuber, N Klugbauer, P Ruth, H D Allescher.   

Abstract

Nitric oxide/cGMP/cGMP kinase I (cGKI) signaling causes relaxation of intestinal smooth muscle. In the gastrointestinal tract substrates of cGKI have not been identified yet. In the present study a protein interacting with cGKIbeta has been isolated from a rat intestinal cDNA library using the yeast two-hybrid system. The protein was identified as cysteine-rich protein 2 (CRP2), recently cloned from rat brain (Okano, I., Yamamoto, T., Kaji, A., Kimura, T., Mizuno, K., and Nakamura, T. (1993) FEBS Lett. 333, 51-55). Recombinant CRP2 is specifically phosphorylated by cGKs but not by cAMP kinase in vitro. Co-transfection of CRP2 and cGKIbeta into COS cells confirmed the phosphorylation of CRP2 in vivo. Cyclic GMP kinase I phosphorylated CRP2 at Ser-104, because the mutation to Ala completely prevented the in vivo phosphorylation. Immunohistochemical analysis using confocal laser scan microscopy showed a co-localization of CRP2 and cGKI in the inner part of the circular muscle layer, in the muscularis mucosae, and in specific neurons of the myenteric and submucosal plexus. The co-localization together with the specific phosphorylation of CRP2 by cGKI in vitro and in vivo suggests that CRP2 is a novel substrate of cGKI in neurons and smooth muscle of the small intestine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681529     DOI: 10.1074/jbc.275.8.5504

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  LIM-only protein, CRP2, switched on smooth muscle gene activity in adult cardiac myocytes.

Authors:  David F Chang; Narasimhaswamy S Belaguli; Jiang Chang; Robert J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

3.  Arabidopsis LIM proteins: a family of actin bundlers with distinct expression patterns and modes of regulation.

Authors:  Jessica Papuga; Céline Hoffmann; Monika Dieterle; Danièle Moes; Flora Moreau; Stéphane Tholl; André Steinmetz; Clément Thomas
Journal:  Plant Cell       Date:  2010-09-03       Impact factor: 11.277

4.  cGMP-dependent protein kinase anchoring by IRAG regulates its nuclear translocation and transcriptional activity.

Authors:  Darren E Casteel; Tong Zhang; Shunhui Zhuang; Renate B Pilz
Journal:  Cell Signal       Date:  2008-03-26       Impact factor: 4.315

5.  Reduced inflammatory hyperalgesia with preservation of acute thermal nociception in mice lacking cGMP-dependent protein kinase I.

Authors:  Irmgard Tegeder; Domenico Del Turco; Achim Schmidtko; Matthias Sausbier; Robert Feil; Franz Hofmann; Thomas Deller; Peter Ruth; Gerd Geisslinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

6.  Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans.

Authors:  Cynthia Sung; Tom J Parry; Todd A Riccobene; Angela Mahoney; Viktor Roschke; James Murray; Mi Li Gu; Jeffrey K Glenn; Florence Caputo; Cindy Farman; Daniel J Odenheimer
Journal:  AAPS PharmSci       Date:  2002

7.  cGMP-mediated signaling via cGKIalpha is required for the guidance and connectivity of sensory axons.

Authors:  Hannes Schmidt; Matthias Werner; Paul A Heppenstall; Mechthild Henning; Margret I Moré; Susanne Kühbandner; Gary R Lewin; Franz Hofmann; Robert Feil; Fritz G Rathjen
Journal:  J Cell Biol       Date:  2002-11-04       Impact factor: 10.539

8.  Cysteine-Rich LIM-Only Protein 4 (CRP4) Promotes Atherogenesis in the ApoE-/- Mouse Model.

Authors:  Natalie Längst; Julia Adler; Anna Kuret; Andreas Peter; Peter Ruth; Karsten Boldt; Robert Lukowski
Journal:  Cells       Date:  2022-04-17       Impact factor: 7.666

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.